Brief: Syros Pharmaceuticals - On March 7, Entered Into Master Collaboration Agreement And Project Schedule With Qiagen Manchester Limited
08/03/2022 12:48
March 8 (Reuters) - Syros Pharmaceuticals Inc SYRS.O :
* SYROS PHARMACEUTICALS - ON MARCH 7, ENTERED INTO MASTER
COLLABORATION AGREEMENT AND PROJECT SCHEDULE WITH QIAGEN
MANCHESTER LIMITED
* SYROS PHARMACEUTICALS INC - QIAGEN HAS AGREED TO DEVELOP
AND
COMMERCIALIZE AN ASSAY AS A COMPANION DIAGNOSTIC TEST
Source: [https://bit.ly/3KoZCWq]
Further company coverage: SYRS.O
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial